Recursion Pharmaceuticals Inc Clas (RXRX)
Stock-Based Compensation
$90.72M
TTM · Period ending: · USD
RXRX Stock-Based Compensation
Latest reported$90.72Mperiod ending
Latest reported$90.72Mperiod ending
RXRX Stock-Based Comp ($1.39M → $90.72M)
Annual stock-based compensation
High-resolution chart · PNG
RXRX stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 111,223,000 | |
| 81,688,000 | |
| 53,503,000 | |
| 27,909,000 | |
| 14,842,000 | |
| 4,292,000 | |
| 1,385,000 |